Terazosin labels and packages

Jump to navigation Jump to search
Terazosin
Terazosin®, Hytrin® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Terazosin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Labels and Packages

PRINCIPAL DISPLAY PANEL TERAZOSIN HYDROCHLORIDE CAPSULES 1 MG

Terazosin Hydrochloride

Capsules 1 mg.*

10 Capsules

PRINCIPAL DISPLAY PANEL TERAZOSIN HYDROCHLORIDE CAPSULES 5 MG

Terazosin Hydrochloride

Capsules 5 mg.*

10 Capsules

[1]

References

  1. "TERAZOSIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]". Retrieved 7 March 2014.